FIELD: medicine.
SUBSTANCE: in order to realise the method before starting complex treatment content of general triiodthyronine in patients' blood is determined, and if its concentration is within 1.35-1.70 nmole/l reduction of tumour size on 25-50% and more after performing chemoradiotherapy is predicted, if concentration of triiodthyronine is within 0.52-1.10 nmole/l progression of disease after performing chemoradiotherapy is predicted.
EFFECT: obtained results of triiodthyronine content in case of chemoradiotherapy are a prognostic factor of treatment efficiency and can be used in treatment of patients with disseminated skin melanoma for timely selection of patients and application of proper treatment tactics.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL COURSE IN DISSEMINATED SKIN MELANOMA PATIENTS | 2008 |
|
RU2399057C1 |
| METHOD OF ESTIMATING EFFICIENCY OF TREATING PATIENTS WITH HODGKIN'S LYMPHOMA | 2009 |
|
RU2405451C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF AUTOMYELOCHEMORADIATION IN PATIENTS WITH NASOPHARYNGEAL CANCER | 2011 |
|
RU2466405C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT AUTOMYELOCHEMOTHERAPY IN PATIENTS WITH RECURRENT BREAST CANCER | 2008 |
|
RU2393484C1 |
| METHOD FOR TREATING GENERALIZED SKIN MELANOMA | 2005 |
|
RU2301061C2 |
| METHOD OF ESTIMATING EFFICIENCY OF NEOADJUVANT AUTOHEMOCHEMOTHERAPY IN PATIENTS SUFFERING FROM CARCINOMA OF CERVIVAL STUMP | 2008 |
|
RU2375063C1 |
| METHOD OF PREDICTING OF PROCESS ACTIVATION IN PATIENTS WITH HODGKIN'S LYMPHOMA | 2009 |
|
RU2405454C1 |
| METHOD OF TREATING RECURRENT NASOPHARYNX CANCER | 2009 |
|
RU2420333C2 |
| METHOD FOR PREDICTING EFFICIENCY OF AUTOHEMOCHEMOTHERAPY IN PATIENTS WITH CANCER OF MOUTH CAVITARY AND PHARYNGEAL ORGANS | 2003 |
|
RU2253354C2 |
| METHOD OF PROVIDED EFFICIENCY OF NON-ADJUVANT AUTOHEMOCHEMOTHERAPY FOR PATIENTS SUFFERING FROM PAGET-TYPE BREAST CANCER | 2007 |
|
RU2328747C1 |
